Advertisement

Topics

Luxottica Group S.p.A. Company Profile

07:51 EST 16th January 2017 | BioPortfolio


News Articles [750 Associated News Articles listed on BioPortfolio]

Luxottica and Essilor to merge in $53 bln deal -FT

Jan 15 (Reuters) - Italian eyewear maker Luxottica and French corrective eye lens maker Essilor have agreed on a 50 billion euros ($53.16 billion) merger, the Financial Times reported, citing people...

UPDATE 4-Luxottica and Essilor agree 46 bln euro merger to create eyewear giant

MILAN/PARIS, Jan 16 (Reuters) - Italy's Luxottica and France's Essilor have agreed a 46 billion euro ($49 billion) merger to create a global powerhouse in the eyewear industry with annual revenue of ...

UPDATE 3-Luxottica, Essilor agree 46-bln euro merger to create eyewear giant

MILAN/PARIS, Jan 16 (Reuters) - Italy's Luxottica and France's Essilor have agreed a 46-billion euro ($49 billion) merger deal to create a global powerhouse in the eyewear industry with revenues of m...

Luxottica, Essilor in 45-bln euro merger deal to create eyewear giant-source

MILAN, Jan 16 (Reuters) - Italy's Luxottica and France's Essilor have agreed a 45-billion euro merger deal to create a global powerhouse in the eyewear industry, a source with knowledge of the matter ...

BRIEF-Luxottica and Essilor agree 50 billion euro merger - FT, citing sources

* Luxottica and Essilor agree 50 billion euro merger - FT, citing sources Source text - http://on.ft.com/2jNCtki Further company coverage: (Bengaluru Newsroom)

UPDATE 2-Luxottica, Essilor in 46 bln euro merger deal to create eyewear giant -sources

MILAN, Jan 16 (Reuters) - Italy's Luxottica and France's Essilor have agreed a 46-billion euro ($49 billion) merger deal to create a global powerhouse in the eyewear industry, two sources with knowled...

UPDATE 1-Luxottica, Essilor in 46 bln euro merger deal to create eyewear giant -sources

MILAN, Jan 16 (Reuters) - Italy's Luxottica and France's Essilor have agreed a 46-billion euro ($49 billion) merger deal to create a global powerhouse in the eyewear industry, two sources with knowled...

BRIEF-Paris-based Essilor-Luxottica to control two independent companies

Jan 16 (Reuters) - Essilor CEO Hubert Sagnieres tells media call:

PubMed Articles [2455 Associated PubMed Articles listed on BioPortfolio]

Improvement of the Marginal Reflex Distance-1 in Blepharoptosis Surgeries.

The aim of this study was to predict the improvement of the marginal reflex distance (MRD1) in each blepharoptosis surgery.In PubMed and Scopus, the search terms 1. (blepharoptosis) AND 2. (surgery) A...

In-Group Versus Out-Group Source Memory.

A common finding in the source monitoring literature is that greater similarity impairs source discriminability. Experiments traditionally manipulate similarity overtly by describing or showing source...

Principles of Psychodynamic Group Psychotherapy.

This paper describes different historical developments of the application of psychodynamic treatments within groups and shows some factors reflecting significant influences on the outcome of group psy...

Histopathologic comparison of dexmedetomidine's and thiopental's cerebral protective effects on focal cerebral ischemia in rats.

This study was designed to investigate whether dexmedetomidine and thiopental have cerebral protective effects after focal cerebral ischemia in rats. Thirty male Sprague Dawley rats were randomly assi...

Protective effects of thoracic epidural anesthesia on hypoxia-induced acute lung injury in rabbits.

The mechanism underlying the effect of thoracic epidural anesthesia (TEA) on hypoxia-induced acute lung injury (ALI) is currently unknown. In the present study, a rabbit acute lung injury model was es...

Clinical Trials [2644 Associated Clinical Trials listed on BioPortfolio]

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Short Term Group Therapy for OCD

Assessing OCD before and after group therapy

Companies [1541 Associated Companies listed on BioPortfolio]

Luxottica Group S.p.A.

Give the Gift of Sight

A Luxottica Group Foundation, Give the Gift of Sight is a family of charitable programs providing free vision care and eyewear to underprivileged individuals in North America and in developing cou...

Luxottica Group

Today Luxottica is an international company listed on the New York and Milan Stock Exchanges, whose strength and success are based on the work and commitment of thousands of people. To understand its ...

Greater Cincinnati Green Business Council

Formed last year, the Greater Cincinnati Green Business Council includes firms dedicated to promoting sustainability while increasing the bottom line. The original members include...

Think About Your Eyes Coalition

Think About Your Eyes is a multi-million dollar two-year public awareness initiative aimed at increasing consumer awareness of the importance of vision health and comprehensive eye exams. Essilor, Lux...

More Information about "Luxottica Group S.p.A." on BioPortfolio

We have published hundreds of Luxottica Group S.p.A. news stories on BioPortfolio along with dozens of Luxottica Group S.p.A. Clinical Trials and PubMed Articles about Luxottica Group S.p.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Luxottica Group S.p.A. Companies in our database. You can also find out about relevant Luxottica Group S.p.A. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record